Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Comment by Investor62on Jun 11, 2021 4:17am
165 Views
Post# 33370647

RE:RE: Desperate times require desperate tactics

RE:RE: Desperate times require desperate tacticsOne should be able to read a press release before making such a statement:
 
In a press release, Dr. Jack Regan, CEO of LexaGEne, said a biopharmaceutical manufacturer purchased the MiQLab System last fall in order to improve quality assurance around its bioreactor work. Regan explained the manufacturer continues to use the system, and the company is now looking to expand the number of targets included in the bioreactor contamination panel.
 
It is clearly written that the biopharmaceutical manufacturer purchased the MiQLab System last fall and is now looking to expand.
Between the lines I read that the system is working as expected (while letsdoit repeated all the time that the machine breaks …)
<< Previous
Bullboard Posts
Next >>